Immuno-Oncology Outlook: Bavencio Leads PD-1/L1 Pack In Ovarian Cancer

 
• By Lucie Ellis-Taitt
Arrows
All marketed PD-1/L1 drugs have ovarian cancer trials ongoing but Bavencio leads the charge • Source: Shutterstock

More from Clinical Trials

More from R&D